INO:NASDAQ
Inovio Pharmaceuticals Inc
US$ १.०१
arrow_upward
+१.००%(+०.०१००) 1D
अक्टोबर २०, १०:२५:२९ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
US$ १.०१
High
US$ १.०२
Low
US$ ०.९९
Mkt. cap
१०.४४ करोड
Avg. vol.
२८.४५ लाख
Volume
३.५२ लाख
52-wk high
US$ २.७२
52-wk low
US$ ०.५६
EPS
-US$ १.१७
Beta
१.६१
Shares outstanding
१०.३४ करोड
No. of employees
११२
Open
US$ १.०१
High
US$ १.०२
Low
US$ ०.९९
Mkt. cap
१०.४४ करोड
Avg. vol.
२८.४५ लाख
Volume
३.५२ लाख
52-wk high
US$ २.७२
52-wk low
US$ ०.५६
EPS
-US$ १.१७
Beta
१.६१
Shares outstanding
१०.३४ करोड
No. of employees
११२
News stories
From web sources and news partners
Local 3 News
·
४६ मिनेट पहिले
RAW: NYSE: OPENING BELL (TUESDAY)
CNBC
·
१ घण्टा पहिले
Investors look to earnings to reset the bull market. The key level to watch on the S&P 500
Yahoo Finance
·
१ घण्टा पहिले
Primech Holdings (Nasdaq: PMEC) Announces Primech AI’s HYTRON Exhibition at CLEAN KOREA 2026 with Exclusive South Korean Distributor NCM
Investing.com
·
३२ मिनेट पहिले
Strive lists SATS preferred stock on Nasdaq at $90 per share
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc